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INTRODUCTION
Intravesical prostatic protrusion (IVPP) is represented as a severe parameter of the 
Bladder outlet obstruction (BOO) due to Benign prostatic hypertrophy (BPH) 
traditionally and it is considered based on the experience that it can be cured only by 
surgical management.But till date it is not made standard in various association 
guidelines and in standard textbooks except for a few publications in literature. In 
symptomatic Benign prostatic hypertrophy patients, there is no consensus or clear 
practical guidelines to define the presence and severity of obstruction, other than the 
pressure-flow study .The latter has been traditionally regarded as the 'reference' gold 
standard but the technique is invasive, uncomfortable for the patient, time-consuming 
and expensive and not available, especially in most developing countries(Ref.Biblio.2). 
The various standard non invasive measures used for finding the severity of Bladder 
outlet obstruction due to Benign prostatic hypertrophy are IPSS score(International 
prostatic symptoms score),Uroflowmetry and Postvoid residual urine 
estimation(PVR).Eventhough these are not considered significant to asses the severity of 
Bladder outlet obstruction on individual basis they are at present used in combination to 
asses the severity.Each one has their own pitfalls to be a single standard non invasive 
mode for assessing the severity of Bladder outlet obstruction due to Benign prostatic 
hypertrophy.Cystoscopy and Pressure flow study are reliable in assessing the severity of 
Bladder outlet obstruction due to Benign prostatic hypertrophy but both are invasive.
New studies are undertaken throughout the world  to find out  reliable single non 
invasive mode to measure the severity of Bladder outlet obstruction due to Benign 
prostatic hypertrophy such as Bladder wall thickness, Obstructive symptoms 
score(OSS), Tranzition zone volume(TZV) etc.(Ref.Biblio.1). The Intravesical prostatic 
protrusion may not be present in all cases of Benign prostatic hypertrophy and hence 
cannont be accomplished as a single non invasive measure for assessing the severity of 
Bladder outlet obstruction due to Benign prostatic hypertrophy.But whomsoever having 
Intravesical prostatic protrusion may be considered to be suffering from severe Bladder 
outlet obstruction and may be taken up for surgical intervention rather than observing 
with medical management. 
The IVPP is caused by mainly median lobe and also enlarging lateral lobes.The natural 
history of the formation of the Intravesical prostatic protrusion includes the Transition 
zone hyperplasia in its proximal end and hyperplasia of the central zone which may 
occur rarely.Also the enlarging lateral lobes,because of the associated bladder 
contraction for the forceful micturition and severe contraction of the bladder neck to 
coapt forcefully, protrudes inside the bladder and forms the Intravesical prostatic 
protrusion.So Intravesical prostatic protrusion may be considered as a severe enlarged 
lateral lobe in its course of enlargement esp when the protrusion is manily formed by the 
lateral lobe. The anatomical configuration of the prostate, in particular the extent of 
intravesical protrusion of the prostate (IVPP), could affect voiding. Intravesical 
protrusion of the prostate causes a 'ball-valve' type of obstruction which is the main 
mechanism depicted for its severity in Bladder outlet obstruction. Intravesical protrusion 
of the prostate disrupts the funnelling effect of the bladder neck and causes dyskinetic 
movement of the bladder during voiding.The strong bladder contraction could force 
open a channel between the lobes but tend to aggravate the ball-valve effect in 
intravesical protrusion of the prostate (IVPP)This mechanism differentiates the 
Intraurethral prostatic protrusion(IUPP) to be a less severe parameter in Bladder outlet 
obstruction.(Ref.Biblio.1&16).
The Intraurethral prostatic protrusion gives way because of the forceful bladder 
contraction and considered to be an early level of progressing lateral lobe enlargement. 
The Intraurethral prostatic protrusion cannot be assessed by radiological investigation 
and even cystoscopy can only delineate the length of the Intraurethral prostatic 
protrusion and cannot asses the depth and height of protrusion.Bladder wall thickness is 
accounted recently by many people as a non invasive measure for assessing the severity 
but the vary of thickness with bladder volume and subjective and objective errors in 
measurement of the wall thickness makes this parameter yet to be standardized.
In our study the grades of Intravesical prostatic protrusion detected by 
TAUS(Transabdominal Ultrasound) correlated with the severity of Bladder outlet 
obstruction (BOO) as assesed by Uroflowmetry,Postvoid residual urine 
measurement,IPSS scoring and Pressure flow study(PFS).Also the effects of medical 
and surgical treatment in patients with IVPP are compared. Intravesical prostatic 
protrusion(IVPP) is correlated with International prostate symptoms score 
(IPSS),Quality of life index (QOL),Uroflowmetry,Postvoid urine (PVR) and Pressure 
Flow study (PFS) and to asses whether the presence and increasing grades of 
Intravesical prostatic protrusion are directly correlated with the severity of Bladder 
outlet obstruction due to Benign prostatic hypertrophy. Response of patients with 
Intravesical prostatic protrusion of same grade to surgical therapy and drug therapy are 
compared to decide which modality of management is best.The abstract stating the aim 
and methods and the powerpoint presentation of the this study is presented to the Ethical 
committee and got approved for the completion of the study
                    
                                REVIEW OF LITERATURE
Bladder outlet obstruction (BOO) is characterized by increased detrusor pressure and 
reduced urinary flow rate. Pressure-flow studies are the gold standard for BOO 
determination. However, this method is an invasive and expensive procedure with 
limited availability. Therefore, attempts have been made to diagnose BOO through 
noninvasive methods that can be divided into 2 categories: non-urodynamically based 
measurements and noninvasive urodynamics. 
Non-urodynamically based measurements include symptoms, post-void residual urine 
(PVR), Prostate Specific Antigen (PSA) and ultrasound derived measurements, such as 
Tuberculoid Leprosy (TT):
prostate volume, bladder wall thickness, bladder weight and intravesical prostatic 
protrusion (IVPP). Noninvasive urodynamics include uroflowmetry, use of a penile cuff, 
the condom-method and Doppler urodynamics .All the non invasive modalities are 
discussed in this literature review and IVPP is compared with the other parameters and 
assesesed for its accuracy and stance in detecting the severity of BOO due to BPH.
It is well known that the prostate's anatomic conformation together with intravesical 
prostatic protrusion (IVPP) may affect normal voiding. Earlier studies have previously 
demonstrated that the ultrasonographic measurement of IVPP could identify BOO. A 
total of 200 patients were assessed with invasive urodynamics and transabdominal 
ultrasound. The relationship of IVPP to BOO showed that as IVPP grade increased in 
severity, BOO grade also increased. The sensitivity and specificity of diagnosing BOO 
were 76% and 92% for over 10 mm IPP, 17% and 53% for between 5 and 10 mm IPP 
and 7% and 56% for under 5 mm IPP, respectively. PVR more than 100 mL showed 
75% sensitivity and 91% specificity for predicting BOO in the population studied. 
LUTS are one of the most common complaints in the elderly men and benign prostate 
obstruction is one of the most frequent causes. Pressure flow study has been 
recommended before surgical treatment of prostate enlargement by many authors. 
Searching for new accurate methods that could substitute the gold standard pressure-
flow study demonstrates the need for lowering costs, expanding accessibility and 
relieving patient discomfort .
Since transrectal methods can produce great discomfort to the patient, abdominal 
ultrasound was demonstrated to be equivalent to rectal ultrasound for measuring the 
prostate when bladder volume is over 100 ml. Clinical data such as IPSS, post voiding 
residue and flowmetry have been previously demonstrated to correlate mostly to lower 
urinary tract functional status rather than mechanical obstruction itself. Therefore, 
noninvasive measurements of the prostate intend to delineate a morpho-functional 
correlation in order to orient conduct towards LUTS secondary to benign prostate 
obstruction.
Chia et al. demonstrated the possibility of using the IVPP measurements for diagnosing 
BOO, which was also a predictor of the capacity for spontaneous voiding after acute 
urinary retention in Tan et al. study .Other authors have suggested determining bladder 
weight, bladder wall width or prostate conformation through abdominal or rectal 
ultrasound.Kojima et al. demonstrated, studying 104 patients, that the bladder weight 
more than 35 g  performed thought transabdominal ultrasound is strongly associated 
with bladder outlet obstruction on pressure-flow studies.
A bladder wall thickness of 5 mm appeared to be the best cutoff point to diagnose 
bladder outlet obstruction, since 63.3% of patients with bladder wall thickness less than 
5 mm were unobstructed while 87.5% of those with a bladder wall thickness 5 mm or 
greater were obstructed in a study including 174 patients of Manieri et al. at 150 mL 
bladder filling.
Hakenberg et al. found that mean bladder wall thickness was 3.33 mm in healthy men 
and 3.67 mm in men with LUTS and BPE, measuring all patients at different bladder 
fillings. BOO was found in 95.5% of men with a detrusor wall thickness greater than or 
equal to 2 mm in Oelke et al. study, at 250 mL or more bladder filling.Recently, Blatt et 
al. who performed urodynamics evaluation and abdominal ultrasound among patients 
with different types bladder dysfunction, found that mean bladder wall thickness in 
patients with normal urodynamics, bladder outlet obstruction, detrusor overactivity and 
increased bladder sensation was 2.0, 2.1, 1.9 and 1.8 mm, respectively. No significant 
difference was found between the groups. In particular, there was no difference in 
bladder wall thickness between patients with normal urodynamics, and those with 
bladder outlet obstruction (p = 0.31) or detrusor overactivity (p = 0.31).The 
inconsistency as regards the results obtained and the lack of technique standardization 
have limited their clinical use until now.
Single Nonurodynamic Measures:
SYMPTOMS: The association between LUTS and BOO has been investigated in many 
studies. A large multicenter,multinational trial such as the International Continence 
Society-“BPH” study in 1,271 men between 45 and 88 years old showed the relationship 
to be poor. This study evaluated a subpopulation of 933 patients with suitable pressure 
flow data and used the validated International Continence Society male questionnaire to 
evaluate storage and voiding symptoms. This was regardless of whether one examined 
voiding and storage symptoms separately. Some studies show a weak correlation 
between voiding symptoms and BOO.Reynard and Abrams found that the symptoms of 
hesitance and decreased flow were statistically significantly related to BOO (chi-square 
test p _ 0.04 and 0.002, respectively). However, the symptoms of straining to void, 
intermittence and terminal dribble were not observed to be associated with BOO by the 
same group. Despite statistical significance due to large patient numbers these symptoms 
have limited clinical significance.
Further quantification of symptom severity by scoring using a validated self-
administered questionnaire, such as the AUA symptom score, has shown a poor 
relationship with BOO and the ability of the AUA symptom score to diagnose BOO is 
also poor. The fact that older women have a
high AUA score suggests that the questionnaire is not disease specific. The International 
Prostate Symptom Score is derived from the AUA symptom questionnaire with an 
additional quality of life question. Not surprisingly this instrument also shows weak 
correlation with objective measures of BOO (r _ 0.18). Symptoms are important for 
managing BOO because they are what bothers the patient but they are insufficient alone 
to diagnose BOO. However, a substantial number of clinicians base their prostate 
surgery decisions on symptom severity alone. 
Biochemical Parameters:
PSA: In a study of more than 300 patients the relationship between PSA and urodynamic 
BOO was examined and stratified using logistic regression analysis. If PSA was 4 to 6 
ng/ml, definite BOO was likely in 65% of cases, whereas if PSA was in the range of 6 to 
10 ng/ml, the likelihood of obstruction increased to 81%. The approach is limited since 
only 23% of the population studied could be stratified in this fashion and had PSA more 
than 4 ng/ml. Furthermore, PSA is also a marker of prostate cancer, which may need to 
be excluded, especially at PSA greater than 4 ng/ml. Therefore, if it is used, clinical 
assessment becomes more complex.
Single Ultrasound Measurements:
PVR: PVR is a useful parameter for assessing patients presenting with LUTS. The 
pathophysiology of increasing PVR is not generally well understood, and interactions 
with BOO and detrusor contractility are complex. It is known that increased PVR occurs 
in patients with BOO. However, a large PVR may reflect detrusor underactivity rather 
than BOO. A third of patients with BOO do not have significant PVR. Nevertheless, 
PVR has been shown to decrease in patients with BOO after surgery.
The interaction of detrusor contractility, PVR and BOO was recently investigated in 131 
patients. This showed that there was a weak correlation between PVR and BOO, and 
PVR alone could not predict BOO. This demonstrates that PVR depends on BOO and 
detrusor contractility, and conversely PVR cannot predict BOO alone. Briefly, PVR 
alone cannot be used to diagnose BOO with good sensitivity but is useful in conjunction 
with other parameters, such as uroflowmetry.
PROSTATE SIZE: Prostate size is usually assessed by DRE, TRUS or magnetic 
resonance imaging. The accuracy of DRE for assessing prostate size is poor. TRUS is 
the imaging modality used most frequently to assess prostate volume and it is more 
accurate than DRE. The relationship between total prostate volume and BOO has been 
investigated in several studies. A retrospective study in 521 patients showed a relatively 
weak but statistically significant correlation of prostate size and BOO (r _ 0.32, p 
_0.001).24 of patients with a prostate volume of more than 40 ml 70% would have been 
diagnosed with BOO. This group represented 45% of the population group and, 
therefore, it is not sufficient alone to diagnose BOO in the majority of patients. In the 
data presented the sensitivity and specificity of a prostate volume of greater than 40 ml 
was 49% and 32%,respectively. In 525 patients Eckhardt et al also noted a statistically 
significant correlation between prostate volume and BOO (r _ 0.28, p _0.001). However, 
unexpectedlyprostate volume decreased slightly as the Schafer grade of obstruction 
reached 5 and 6.
With the failure of total prostate volume alone to diagnose BOO attempts have been 
made to diagnose BOO using prostate shape and the relative proportions of the different 
prostate zones. The zonal anatomy of the prostate consists of 3 zones, that is a central 
zone, a TZ and peripheral zone. The TZ is the major site of benign prostatic hyperplasia. 
The TZ index, that is the ratio of TZ volume to total prostate volume, was reported by 
Kaplanet al in 61 patients to have a stronger statistically significant correlation with 
symptoms (r _ 0.75, p _ 0.001) and maximum urine flow (r _ _0.71, p _ 0.001) than with 
prostate volume alone. However, TZ had only a moderate correlation with detrusor 
pressure at maximum flow(r _ 0.43). Witjes et al investigated 150 patients using 
prostatic volume, TZ index and pressure flow studies, and failed to note any significant 
relationships. They believed that none of these parameters used singly was sufficient to 
diagnose BOO. Lepor et al also reported that total prostate volume and TZ dimensions 
correlate poorly with symptoms and have inadequate correlations with BOO for clinical 
usefulness. The TZ index is insufficient alone to provide the diagnosis of BOO.
Prostatic configuration has been investigated using prostate PCAR (Presumed circle-to-
area ratio), as observed on TRUS. PCAR measures the degree to which the transverse 
ultrasound image of the prostate approaches a circular shape. The ratio tends toward 1 as 
the prostate becomes more circular. In 85 patients PCAR showed a stronger correlation 
than the TZ index (r _ 0.487, p _0.0001 vs r _ 0.331, p _0.005). In addition, PCAR 
sensitivity was 77% for diagnosing obstruction when PCAR was greater than 0.8 with 
75% specificity. It seems clear that the more circular the prostate, the more likely there 
is to be BOO. This has notbeen repeated in further, larger studies.
BLADDER WALL THICKNESS AND BLADDER WEIGHT:
BWT is a variable that has been used to assess BOO noninvasively. The rationale of 
BWT as a parameter for diagnosing BOO is that increasing prostatic obstruction is 
associated with detrusor hypertrophy, leading to increased BWT. This has been shown 
to occur in some morphological studies. However, an increase in BWT may result not 
only from
smooth muscle hypertrophy, but also from the increased fibrous tissue and collagen that 
occurs with age and obstruction.
Experimental animal models of obstruction have shown increased detrusor hypertrophy, 
which decreases after obstruction is released. However, an increase in BWT may not 
necessarily be related only to BOO alone. It could be due to age or detrusor overactivity.
BWT measurement is significantly influenced by bladder volume. The bladder wall 
stretches as bladder volume increases therefore, decreasing the BWT measured. Several 
methods have been suggested to overcome this factor. Kaefer et al noted in a small 
group of children, including 15 with posterior urethral valves and 10 who were normal, 
that there is an inverse relationship between bladder radius and BWT. To overcome this 
the bladder thickness index was developed. The bladder thickness index was calculated 
from 4 BWT measurements (dome, floor and 2 lateral walls) divided by the average of 2 
internal bladder measurements (to represent bladder volume). This bladder thickness 
index standardizes BWT with regard to bladder volume, although the calculation 
assumes a spherical bladder. This index was found to have 80% sensitivity and 90% 
specificity for predicting BOO.
Manieri et al circumvented the problem of bladder volume by measuring BWT at a 
constant volume of 150 ml during urodynamic procedures in adults. A total of 174 male 
patients with LUTS were examined with 3 measurements of BWT at 3 sites (anterior 
and lateral walls). Average
BWT correlated with urodynamic parameters of obstruction, as measured by the 
Abrams-Griffiths number (r _ 0.6724, p _0.0001). Of 58 patients with a BWT of greater 
than 5 mm 88% had obstruction on pressure flow studies. The specificity of BWT more 
than 5 mm for diagnosing BOO was 92%,although sensitivity was 54%. Furthermore, 
the need for measurement at a standard volume may make it difficult to use this in 
clinical practice. In 70 patients others determined a cutoff of BWT more than 2 mm for 
diagnosing BOO with 63.6% sensitivity and 97.3% specificity. Normative data on 172 
asymptomatic male patients showed that BWT increases with age (r _ 0.12, p _0.014) 
and normal mean BWT _ SD is 3.3 _ 0.08.41 In addition, a comparison of normal, age 
matched, asymptomatic men, and male patients with LUTS and BPE showed no 
significant difference in mean BWT. A statistically significant negative correlation was 
also found between bladder volume and BWT, supporting the use of a fixed volume, as 
suggested by Manieri et al (r _ _0.12, p _0.003).39 Some groups suggested that BWT 
remains stable at greater than 60% to 100% of bladder capacity but it varies across the 
initial 50% of bladder capacity. Kojima et al suggested calculating bladder weight as a 
measure of detrusor hypertrophy, which allows measurement at different bladder 
volumes.
UEBW(Ultrasound estimated bladder weight) is calculated as follows. The total bladder 
volume, including BWT, is measured, assuming that the bladder is a sphere. An average 
of 3 points at the anterior bladder wall 1 cm apart is used to calculate BWT. Total 
volume is subtracted from intravesical volume, as determined on ultrasound, and 
multiplied by the specific gravity, which is approximated as 1. In the initial study this 
was repeated using a simple ellipsoid model. In an autopsy study bladder weight was 
calculated using 10 cadaver human bladders after filling. The sphere and ellipsoid 
models showed similar results and correlated with actual bladder weight. Because the 
spherical model was simpler to calculate, this method was adopted in subsequent 
studies. The reliability of UEBW calculations at different bladder volumes was studied 
in only 16 patients using 100 to 300 ml volumes. This appeared to show an average 
mean variation of 5 gm or 12% but sample size was insufficient to make further 
statements about the reproducibility of UEBW measurement. In the same study UEBW 
was shown to have different distributions in normal asymptomatic, nonobstructed
and obstructed populations. Intra-investigator and interinvestigator variations in UEBW 
in 36 patients were studied and showed no statistical difference. Mean initial and second 
measurements were 42.8 _ 22.6 and 42.9 _ 22.6 gm, respectively.
A comparison of UEBW with pressure flow studies in 65 patients demonstrated a 
significant correlation with urodynamic parameters of obstruction, such as the Abrams-
Griffiths number and Schafer grade of obstruction (r _ 0.478, p _0.0001 and r _ 0.543, p 
_0.0001, respectively).
Using an UEBW cutoff of greater than 35 gm test sensitivity was 85% with 87% 
specificity. Nevertheless, there were patients with a substantially increased UEBW who 
did not have obstruction. UEBW defines detrusor hypertrophy but not the cause, which 
may not necessarily be prostatic obstruction. The effect of detrusor overactivity on 
UEBW was not considered, although it seems likely that bladder weight may be 
increased in cases of detrusor overactivity without obstruction. 
In a subsequent study a group investigated the change in UEBW parameters before and 
after prostate surgery. A total of 33 patients were treated with retropubic subscapular or 
transurethral prostatectomy. The criteria for surgery were determined from TRUS 
findings and clinical findings of increased PVR. In the majority of these select patients 
UEBW changed from a mean of 53 to less than 35 gm 12 weeks after surgery. 
Interestingly in 3 patients with UEBW greater than 80 gm UEBW remained greater than 
35 gm after surgery. A pilot study of the change in UEBW parameters after tamsulosin 
treatment in 32 patients demonstrated a decrease in UEBW at 30 days that was 
maintained at 6 months. However, this was not a double-blind study, raising the 
possibility of observer bias.In conclusion, the limitations of the method include 
variability in the number of different sites on the anterior bladder wall used to derive 
BWT and UEBW. Variation in BWT with bladder volume is an issue. Repeatability of 
the methodology, and further assessment of interinvestigator and intra-investigator 
variability in the measurement of ultrasound parameters are also required. In cases of 
UEBW cumbersome calculations are required and they depend on the accurate 
measurement of bladder volume as well as BWT.
IVPP ON TRANSABDOMINAL ULTRASOUND:  The rationale for
this approach is based on the fact that, as the prostate enlarges, it protrudes into the 
bladder, producing a ball valve effect and leading to BOO.IVPP is measured in mm 
from the bladder base in the mid sagittal line using transabdominal ultrasound. IVPP is 
graded according to severity as grade I—less than 5 mm, grade II—5 to 10 mm and 
grade III—more than 10 mm. In 22 anesthetized patients before TURP the effect of 
bladder volume on IVPP was investigated. The effect of bladder volume on protrusion 
was significant with an 80% increase (mean 4 mm) in the mean measurement as bladder 
volume decreased from 400 to 100 ml. The investigators suggested that IVPP should be 
measured between bladder volumes of 100 and 200 ml.
The same approach was used to assess the role of IVPP for determining the outcome of 
TWOC(Trial without catheter) after acute retention in 100 patients. As predicted by 
IVPP, the failure rate of TWOC for grades I to III was 36%, 58% and 67%, respectively 
(grade 1 vs 3 chi-square test p _ 0.008). The greater the grade of IVPP, the more the 
chance of TWOC failure. A total of 200 patients were assessed with invasive 
urodynamics and transabdominal ultrasound. The relationship of IVPP to BOO is such 
that, as IVPP grade increases in severity, the severity of BOO increases. The sensitivity 
and specificity of diagnosing BOO were 76% and 92% for grade III, 17% and 53% for 
grade II and 7% and 56% for grade I, respectively. PVR more than 100 ml showed 75% 
sensitivity and 91% specificity for predicting BOO in the population studied. 
There is variability in ultrasound measurement which should be handled by a single 
person on a same ultrasound machine and a test/retest of this echnique has not been 
published. The large effect of bladder volume on IVPP measurements should be tackled 
by measuring the IVPP in a constant volume say 100-200 ml. This measure requires 
further replication at other centers and its significant clinical application for diagnosing 
BOO yet to reproduced in various centres.
Doppler RI:
Some animal models suggest that detrusor blood flow is decreased in obstructed vs 
nonobstructed animals. This is because the detrusor undergoes compensatory 
hypertrophy with no increase in blood supply and, therefore, a relative decrease in blood 
flow. A pilot study investigated detrusor blood flow, as determined by color Doppler 
ultrasound in 29 patients who also underwent pressure flow studies. Average arterial 
blood flow at 3 bladder sites was measured as well as the RI, which is an index of 
change in blood flow calculated by the formula, RI _ Vmax _ Vmin/Vmax, where Vmax 
represents maximum velocity and Vmin represents minimum velocity. A statistically 
significant difference was noted between detrusor RI values in obstructed and 
nonobstructed cases. A logistic regression model was developed to predict BOO. This 
showed an overall accuracy of 86% but a
low negative predictive value of 57%. A larger study is re-quired to investigate this 
further. However, it must also be recognized that other factors affect the change in blood 
flow, including atherosclerosis, age and detrusor overactivity.
RI has been evaluated in patients with LUTS using a transrectal approach. Of 140 
patients RI was measured in 57 patients undergoing pressure flow studies. There was a 
correlation of RI with prostatic parameters, such
as PCAR, the TZ index and patient age (r _ 0.456, p _0.0001, r _ 0.276, p _0.01 and r _ 
0.337, p _0.005, respectively). Furthermore, there appeared to be some correlation 
between the RI and the Abrams-Griffiths number (r _ 0.330, p _0.05). When the RI was 
greater than0.7, sensitivity and specificity for diagnosing BOO were85% and 46%, 
respectively. However, the mechanism responsible for the increased RI in benign 
prostatic hyperplasia is not understood.
Numerous nonurodynamic approaches have been investigated as alternatives to pressure 
flow studies in men. It is important that studies suggesting a new diagnostic test should 
follow good methodological standards to allow accurate evaluation of the findings. 
Unfortunately there is poor compliance in such studies with the good methodological 
standards required for defining new diagnostic tests. Further vigilance is required on the 
part of journals to ensure that suchstandards are upheld.
Reviewing the diagnostic accuracy of the different methods of diagnosing BOO shows 
that there appears to be large variation in the sensitivity and specificity of the measures 
considered. For example, symptoms appear to offer excellent sensitivity but poor 
specificity for diagnosing BOO compared to bladder weight and IVPP, which offers 
good sensitivity and specificity. However, sensitivity and specificity relate more to the 
yes/no accuracy of the test rather than to its usefulness in a clinical context. Positive 
predictive values are important in clinical evaluation but they vary according to the 
prevalence of BOO in the population studied. Therefore, it is important to know the 
pretest probability of BOO in each study, which varies from 47% to 75%. It follows that 
LRs are important because they determine the level of change from pretest to posttest 
probability for diagnosing BOO. Most measures show modest increases from pretest to 
posttest probability for diagnosing BOO except IVPP, BWT and UEBW. IVPP requires 
further replication in Western populations. BWT and UEBW are promising emerging 
tests with a good evidence base to support their use in entering clinical practice after 
further development. However, there is a need to standardize the measurements used to 
assess BWT and determine UEBW in Western populations. 
Uroflowmetry:
Uroflowmetry provides an objective indication of voiding dysfunction. The limitation of 
urinary flow rates are that they do not distinguish a low flow rate due to prostatic 
obstruction from low flow due to poor detrusor contractility. Furthermore, patients with 
obstruction who have high detrusor pressure can maintain a normal flow rate. 
Uroflowmetry results show considerable variation in Qmax measured on the same or on 
different days.
The specificity of Qmax for BOO depends on a number of factors, for example the 
volume voided and the value of Qmax used, ie less than 10 ml per second. The 
specificity and positive predictive value of Qmax less than 10 ml per second were 
reported in the ICS-“BPH” study as 70% but with 47% sensitivity. However, 60% of the 
population in the ICS- “BPH” study had obstruction. Therefore, it can be argued that the 
value of Qmax less than 10 ml per second only improves the PPV by 10% and really 
does not add much additional information. Single center studies, albeit with smaller 
patient numbers, suggest a higher specificity of 90%, in particular when multiple flows 
were done. The limitation of this approach remains the poor sensitivity of Qmax less 
than 10 ml per second unless flow studies are performed in a structural manner.
Non Invasive Urodynamics:
The underlying principle of noninvasive urodynamic techniques is the measurement of 
isovolumetric bladder pressure. In combination with the free flow rate it would allow a 
slow flow rate due to obstruction to be distinguished from a low flow due to detrusor 
underactivity. The penile cuff and modified condom method are the 2 principle methods 
used to
measure isovolumetric bladder pressure. These 2 methods rely on the assumption that 
there is a continuous column of fluid between the bladder and urethra when flow is 
interrupted, so that pressure at the point of measurement is the same as pressure in the 
bladder. 
The external condom method was first suggested by Schafer.The patient voids 
repeatedly through a condom catheter. At maximum flow the catheter is blocked and 
isovolumetric pressure is measured. In the first reported study all patients underwent 
pressure flow studies and the condom method. There was a 25% failure rate, leaving 56 
patients with interpretable results. Several strategies for analyzing the data were used. 
The best method of diagnosing BOO using the condom method (penile external 
pressure) and Qmax showed 64% sensitivity with 79% specificity, as calculated from 
data presented in the article. However, this involved combining the data on the 
unobstructed and equivocal groups. Several significant problems have been noted when 
using this technique. Sometimes in some patients isovolumetric pressure was not 
attained. There was a decrease in the correlation of pressure in patients with obstruction. 
Also, the method could not be used to diagnose BOO at lower flow rates (less than 5.4 
ml per second). To overcome these problems the use of a variable resistance catheter as 
well as preloading the condom with water was suggested. Subsequently a large 
longitudinal study was performed, which showed improved applicability and 
reproducibility. Two methods have been suggested for the penile cuff technique, that is 
the deflation and interruption techniques. As suggested by Gleason et al, the original 
penile cuff technique was the deflation technique.  The penile cuff was used to occlude 
the urethra on penile shaft before voiding. The patient was instructed to void and the 
cuff was deflated slowly by the patient using a button when urine was felt in the urethra. 
After a flow rate of greater than 1 ml per second was detected by the flowmeter the cuff 
was rapidly deflated.
The penile interruption technique was proposed by the Newcastle group.  The penile 
cuff is automatically inflated after voiding commences at a stepwise increment of 10 cm 
H2O per second to a maximum of 200 H2O. After voiding ceases the cuff is rapidly 
deflated, resulting in a surge of urine (Qsurge), followed by a steady state of urine flow 
(Qss). This cycle is repeated through the course of the void. Using simultaneous 
invasive urodynamics and the penile cuff isovolumetric detrusor pressure was reliably 
estimated by the cuff. However, mean cuff pressure _ SD overestimated bladder 
pressure by 14.5 _ 14 cm H2O. This difference is partly explained by the height 
difference between the symphysis pubis and the middle of the cuff. A further, larger 
study in 151 patients showed that overestimation of mean cuff pressure was 16.4 _ 27.5 
cm H2O. Test/retest variability was 0 _ 20.3 in patients with a VV of at least 150 ml. 
Interobserver agreement in the analysis of the results was good.  Of the patients 80% 
preferred the cuff to invasive urodynamics.
To diagnose BOO a modification of the ICS nomogram has been suggested for the 
penile interruption cuff technique. This nomogram considers that abdominal pressure is 
not measured and it makes a conversion of detrusor pressure at Qmax used in the ICS 
nomogram to isovolumetric pressure. Combinations of noninvasive urodynamic 
parameters were investigated by Harding et al in 116 patients from 2 centers.  Using 
linear discriminant analysis patients were plotted on a 3-dimensional nomogram of flow 
rate, cuff pressure and the PCR index. The combination of these 3 parameters provided 
86% and 87% sensitivity, respectively, for diagnosing BOO. Furthermore, they defined 
the diagnostic parameter N, corresponding to the Abrams-Griffiths number, as N _ 
internal cuff pressure – 6.4 Qmax _ 0.35 PCR, where N greater than 100 indicates 
obstruction. A further study is in progress to assess the outcome of transurethral prostate 
resection using the modified ICS nomogram.Preliminary results show that preoperative 
assessment using the modified ICS nomogram improves the outcome
of transurethral prostate resection.
The pinch test exploits the same principles as the cuff test. Urine flow waveforms after 
penile compression and release have been investigated as a possible method of 
diagnosing BOO. Sullivan and Yalla investigated manual pinching of the penis in 110 
patients. The PCR (Penile compression release) index was formulated by the equation, 
(Qsurge – Qss)/Qss *100.The PCR index was found to be different in obstructed, 
nonobstructed, detrusor underactivity and detrusor overactivity groups. In fact, a PCR 
index of greater than 100% had the ability to diagnose BOO in the population studied 
with 91% sensitivity and 70% specificity. When the cuff test was used to calculate PCR, 
a PCR index of 160% provided 78% sensitivity and 84% specificity for predicting BOO. 
Furthermore, it showed a positive correlation of isovolumetric pressure with the PCR 
index (r _ 0.44, p _0.01). In conclusion, noninvasive urodynamics may have the 
possibility of providing a noninvasive diagnosis of BOO, although one must note that 
abdominal straining may affect the result. The techniques and pitfalls have been well 
covered previously. The combination of the noninvasive urodynamics parameters 
isovolumetric detrusor pressure, PCR index and Qmax form a potentially accurate 
method of diagnosing BOO.
Doppler Ultrasound Urodynamics:
Doppler ultrasound is usually used to measure blood flow velocity. Initially the 
application of Doppler ultrasound was thought unlikely to be useful for measuring 
urinary flow since there are no cells in urine to reflect ultrasound waves and, hence, a 
Doppler effect would not occur. However, in an experimental model urine but not 
degassed water was continuously detected when the flow rate was greater than 1.5 ml 
per second. Therefore, it was surmised that Doppler works because microbubbles are 
created by the urinary flow. However, flow must be greater than 1 to 3 ml per second to 
be measured by Doppler ultrasound. The technique of Doppler flow measurement has 
been applied to measure urine flow in the prostatic urethra, which is the site of the flow 
controlling zone. Clinical application requires the patient to be seated with the probe 
positioned perineally by a robotic arm. The technique was initially evaluated in 6 
patients with and 6 without BOO. This demonstrated that the functional cross-sectional 
area calculated by dividing Qmax by maximum flow velocity, as determined by Doppler 
ultrasound, was lower in the BOO than in the control group (mean 0.31 _ 0.16 vs 0.78 _ 
0.23 cm2, p _ 0.006). Further clinical evaluation was performed in 22 patients with 
pressure flow studies as well as Doppler ultrasound investigation. Further parameters 
evaluated were flow velocity
in the distal prostatic (V1) and membranous (V2) urethra, and the velocity ratio (VR _ 
V1/V2). The velocity ratio represents the change in flow across the flow controlling 
zone. In patients with obstruction a greater decrease in urine velocity between the 
prostatic urethra and membranous urethra would be expected, resulting in a greater VR. 
Indeed, VR greater than 1.6 showed 60% sensitivity and 100% specificity for diagnosing 
urodynamic obstruction, as shown by pressure flow studies. In a further study of 22 
patients a decrease in VR was observed after _-blocker therapy. V2 had the best 
correlation with the I-PSS change after treatment (r _ 0.584). In conclusion, several 
problems exist with this technique. Although the reliability of the Doppler urodynamic 
test was shown to be reasonable, no test-retest reliability was determined and there was 
large interrater variability in the VR calculation. Some of the difficulty was in where 
exactly V1 and V2 are measured. Furthermore, it requires expensive and specialized 
equipment to perform. The technique requires the patient to be cooperative and sit still. 
To date it has only been evaluated in a small number of patients. Also, it is a fact that 
most men void while standing, whereas this technique requires a sitting position.
Combination of single measures:
As discussed, the shortcomings of individual parameters for diagnosing BOO 
noninvasively have led investigators to examine the diagnostic potential of combining 
different measures. They have used various measurements, including Qmax, PV, PVR, 
VV, AUA score and median lobe enlargement. Qmax and total PV were used by Ockrim 
et al to estimate the BOO index using data on 384 men to construct a formula by logistic 
regression. The equation, which is rather complicated and requires a calculator, is 
antilog10 (2.21 _ 0.5 log maximum urine flow _ 0.18 log total prostate volume). A 
reference table was also constructed. In 42% of the population a predicted BOO index of 
greater than 40 showed 86% sensitivity for obstruction and 92% sensitivity for 
obstruction or equivocal obstruction. However, only 17% of the study population had 
BOO. As determined in 134 patients, the AUA symptom score and Qmax combination 
has provided the highest specificity for BOO of all single measures or combinations. 
Qmax lessthan 10 ml per second and AUA score greater than 20 diagnosed BOO with 
98% specificity and 38% sensitivity, while conversely Qmax greater than 15 ml per 
second and AUA score less than 10 diagnosed nonobstruction with 98% specificity but a 
sensitivity of only 22%. Only 20% of the population studied were categorized as 
obstructed or unobstructed using this method, limiting the efficacy of this approach. 
Steele et al added prostate volume greater than 40 gm to the algorithm, which increased 
specificity to 100% but had only 26% sensitivity, while the population diagnosed 
remained low at 20%. Qmax, PV and relative PVR provided a statistically significant 
correlation with BOO in 196 patients. Relative PVR was defined as PVR divided by 
cystometric capacity, multiplied by 100. An equation was constructed from these 
measurements, that is prostate volume on transrectal ultrasound in cm3 – 3x Qmax + 
(0.25 times relative PVR) to obtain the BOO number. In this population 50% of men 
with BOO were diagnosed with 90% sensitivity when the BOO number was greater than 
_2. BOO was defined as a Schafer grade of 2 or more using the linear passive urethral 
resistance relation. Grade 2 is defined as mild obstruction. However, when the data for 
Schafer grade 3 or above (equivalent to obstruction on the ICS nomogram) were 
reanalyzed, the discrimination between obstruction and nonobstruction disappeared. 
Furthermore, 80% of the population studied had obstruction on urodynamics, which may 
not represent a general population presenting with LUTS and, therefore, may show 
falsely high test reliability. van Venrooij et al further refined their equation to use VV 
instead of relative
PVR and further quantified the probability of obstruction on an individual level. Qmax, 
PV and PVR have shown significant correlations with BOO, which has led to the 
construction of a nomogram to determine the probability of obstruction using logistic 
regression of these measurements. The simple nomogram is categorical in nature with 3 
broad categories of less than 50, 51 to 100 and greater than 100 for PVR and PV, and 
less than 10 and 10 to 15 ml per second for Qmax. Due to the few patients used in 
logistic regression in certain categories its value is probably limited. Furthermore, this 
method has not been validated in an independent set of patients. Qmax, PV, PVR and 
VV were used by Rosier et al with retrospective conventional urodynamic data in 871 
elderly patients to obtain a clinical score to help diagnose BOO.The weighting of each 
component was determined from logistic regression analysis with Qmax most strongly 
weighted. A low Qmax scored up to a maximum of 15 of a total of 27 points. A score of 
greater than 11 showed 80% sensitivity but only 53% specificity for diagnosing BOO. 
The 7 parameters of Qmax, flow pattern, PVR, PV, VV, the transitional zone index and 
median lobe enlargement were used by Kuo in 324 Taiwanese men to construct a 
clinical prostate score for diagnosing BOO. A clinical prostate score of 3 or greater 
using the Kuo scoring system had 87% sensitivity with 61% specificity. However, 54% 
of the population studied would still have required urodynamics to determine BOO 
despite the large number of measures included in his prostate score. The generalizability 
of results from an Asian to a Western population is uncertain. The method of 
construction of combination algorithms uses traditional logistic regression models. The 
limitation of traditional regression models is their inability to determine the complex 
nonlinear relationships that occur in clinical medicine. Artificial neural networks may 
allow the detection of complex nonlinear relationships and improve prediction. The 
disadvantages are the requirement of complicated computation and the risk of over 
fitting data to 1 set of variables. Wadie et al found that traditional logistic regression 
analysis revealed no relationship between I-PSS and objective measures of BOO in 460 
patients. This relationship was reexamined by the same investigators using artificial 
neural networks and then I-PSS was found to predict BOO with 87% sensitivity and 
44% specificity using the same artificial neural networks with the parameters of Qmax, 
I-PSS, PSA, VV and PVR failed to show an advantage over traditional regression 
models for predicting BOO. Further advances in artificial neural networks may help 
develop methods used to predict BOO.
There are outstanding issues in regard to the combination approach ie                 various 
population groups have been used to construct the algorithms, which may limit their 
application to a general population presenting with LUTS. Mostimportantly there 
remains a majority of patients presenting with LUTS who are not assigned to a 
diagnostic group with any certainty, such as patients with a mid range flow rate and 
moderate size prostate with moderate symptoms. The extremes of the population are 
generally easy to categorize,  for example obstruction in patients with a large prostate, 
low Qmax and severe symptoms. Therefore, the algorithms may not tell us anything that 
we do not know from clinical experience. To date there is little evidence that these 
methods decrease the number of men who require pressure flow studies. 
Overall there has been poor compliance with the methodological standards for 
evaluating diagnostic tests. There was insufficient information in published articles to 
assess the validity of some proposed measures. Nevertheless, several approaches appear 
to be rather limited in their reliability and clinical use, including the combination of 
office measures such as AUA symptom score and PV. There appear to be modest LRs 
for single noninvasive urodynamic parameters. Indeed, the largest LR for a single 
noninvasive urodynamic parameter was that for Doppler urodynamics. However, the 
study in question had a small number of patients with poor compliance with preset 
criteria and, therefore, caution is required when interpreting this result. Thereafter the 
PCR index, and the combination of noninvasive urodynamic parameters of the cuff, 
PCR index and Qmax show the best LRs and changes from pretest to posttest probability 
for diagnosing BOO noninvasively However, compared to ultrasound  parameters the 
results are not as impressive This may be partly due to greater variability in measuring 
the dynamic physiological measurements used in noninvasive urodynamics. 
Furthermore, the populations studied with the different methods may not be comparable. 
Ideally a trial comparing ultrasound derivatives and noninvasive urodynamics such as 
the cuff in the same patient population would allow better comparison.
Intravesical protrusion seems to corroborate with urinary obstruction through a "valve 
ball” mechanism, in which the prostate's lateral and medium lobes interfere on the 
complete opening of the vesical neck while the patient urinates. According to this 
mechanism and based on the present study, it was demonstrated that the intravesical 
protrusion of the prostate relates not only to the urinary obstruction itself, but it also 
provides information concerning the severity of obstruction. It has been demonstrated 
that the greater the IVPP, the higher BOOI. Still significant, but to a lesser extent, results 
of prostatic volume obtained through ultrasound and PSA also related to the degree of 
obstruction. 
Utilizing receiver-operator characteristic curves, the area under the curve for IVPP were 
0.772, and 0.858 for Lim et al. and Keqin et al. respectively. The latter authors found 8.5 
mm as the best cutoff value for IVPP with 75.5 % of sensitivity and 82.6 of specificity.
(Ref.Biblio.3,4 &26).Thus the comparison of IVPP with other non invasive parameters 
in detecting the severity of Bladder outlet obstruction due to BPH and modality of the 
best treatment for IVPP whether medical or surgical discussed in various literature are 
debated and presented here.
IVPP shows good accuracy and predictive value in finding out the severity of BOO in 
all studies and higher grades are opted for surgical intervention.
                              A I M 
A. To correlate Intravesical prostatic protrusion(IVPP) with International prostate 
symptoms score (IPSS),Quality of life index(QOL), Uroflowmetry,Postvoid urine 
(PVR) and Pressure Flow study (PFS) and to asses whether the presence and 
increasing grades of Intravesical prostatic protrusion are directly correlated with 
the severity of Bladder outlet obstruction due to Benign prostatic hypertrophy. 
B. Response of patients with Intravesical prostatic protrusion of same grade to 
surgical therapy and drug therapy are compared to decide which modality of 
management is best.
                              
Tuberculoid Leprosy (TT):
                            MATERIALS AND METHODS
1.Prospective study 
2.Period of study is from June 2006 to June 2009.
3.Age Range- 50 to 80 years.
4.The sample size is 100.
5.The patients with co morbid illness such as Diabetes 
Mellitus(DM),Hypertension(HTN),Tuberculosis(TB) etc and associated neurological 
conditions are excluded from the study. Patients with a
known history of previous lower urinary tract surgery, prostate or bladder 
carcinoma,bladder calculi, or neurological deficit are also excluded from the study. 
Intravesical prostatic protrusion(IVPP) is correlated with 
1.International prostate symptoms score (IPSS) 
2.Quality of life index (QOL) 
3.Uroflowmetry 
4.Pressure Flow study(PFS) 
4.Effects of surgical therapy 
5.Response to drug therapy
The initial evaluation consisted of the International prostate symptoms score (IPSS) and 
quality-of-life (QoL) score, a physical examination including a DRE, to exclude tumour, 
and a neurological examination to exclude any neurological deficit and neurologically 
related bladder dysfunction.
The bladder is next assessed by transabdominal ultrasonography (TAUS). The bladder 
had to have a capacity of 150–250 mL before the extent of IPP is measured, by moving 
the sagittal scan of the ultrasound probe both horizontally and longitudinally,and 
assessing the bladder neck for protrusion of the prostate into the bladder. A grading 
system is used, with three grades depending on the degree of IPP, by measuring the 
vertical distance from the tip of the protrusion to the circumference of the bladder at the 
base of the prostate gland.
Intravesical prostatic protrusion(IVPP) is graded into three with Transabdominal 
ultrasound(TAUS) with the bladder volume of 150-200 ml 
Grade I < 5mm,
Grade II -5 to 10 mm 
Grade III >10mm.
This grade is standardly used in various literature and proved to be nominal.Hence taken 
in this study also and all the severity of Bladder outlet obstruction parameters are 
compared with the grades of Intravesical prostatic protrusion. TAUS is used in our 
study, being noninvasive and easy to learn and evaluate. Using the same probe, the 
upper urinary tracts can be easily assessed at the same time. 
 After the Transabdominal ultrasound(TAUS) assessment, the peak urinary flow rate (Q 
max) and voided volume are measured using Uroflowmetry  and the postvoid residual 
urine volume (PVR) is measured by diagnostic ultrasonography of the bladder either 
using the double mode in ultrasound or using the formula L*B*H*0.0523 considering 
the spherical shape.   Prostate volume is measured by diagnostic ultrasonography of the 
bladder either using the double mode in ultrasound or using the formula L*B*H*0.0523 
considering the spherical shape. 
Urine analysis and culture are done. Patients with positive cultures are treated with 
appropriate antibiotics and rendered culture free before proceeding with the protocol. 
Renal Function test is done and patients with renal insufficiency are excluded. Serum 
PSA was also measured and those who had higher values are excluded from the study. 
Cystoscooy is done routinely in all patients eventhogh not indicated in all patients 
according to the standard guidelines after getting the consent.
Delphis TM Laborie urodynamic machine is available in our department only from mid 
2007. The cases enrolled in the study after this period underwent routinely the Pressure 
Flow study using the Delphis TM Laborie urodynamic machine. The pressure flow 
study was conducted on another occasion after cystoscopy, using a double-lumen 
catheter (7–8 F) vesical and rectal catheters; the procedure followed international 
guidelines .BOO was defined by the BOO index (detrusor pressure at Qmax– (2 * 
Qmax)) and then correlated with the clinical variables, including age, IPSS, QoL, Qmax, 
PVR, prostatic volume and IPP grade; the sensitivities and specificities of these 
variables were then calculated. Logistic regression and Pearson correlation were used for 
the statistical analysis and correlation coefficient is calculated for the significance.
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15.Pressure Flow Study (pts who enrolled from mid 2007 onwards underwent PFS)        
Patients who had acute urinary retention are evaluated with IPSS score based on 
symptoms before catheterization and categorized under obstructive pattern 
uroflowmetry(Peak Flow<10ml/sec).Their peak flow is considered 0 ml/sec and PVR > 
300 ml when taken into account for calculating the mean.The Intravesical prostatic 
protrusion is correlated with the severity of Bladder outlet obstruction due to BPH as 
assessed by symptoms score , QOL index,uroflowmetry,cystoscopy and confirmed with 
Pressure Flow study.         
Those patients who are fit and willing for surgery and those patients indicated for 
surgery are proceeded with conventional TURP. The general  indications for 
prostatectomy, by either open approach or transurethral resection, include (1) acute 
urinary retention; (2) recurrent or persistent urinary tract infections; (3) significant 
symptoms from bladder outlet obstruction not responsive to medical therapy; (4) 
recurrent gross hematuria of prostatic origin; (5) pathophysiologic changes of the 
kidneys, ureters, or bladder secondary to prostatic obstruction; and (6) bladder calculi 
secondary to obstruction.But in this study patients with Bladder calculi, Renal 
insufficiency and recurrent gross hematuria are not included.Transurethral resection is 
done completely and resection of complete adenoma is done in all cases monitored 
under supervision.
Other patients are put under drug treatment- a combination of Tamsulozin and 
Dutasteride for a period of 3 months.Many studies has proved that 3 months period of 
drug treatment is adequate for a appreciable and complete initial response for Benign 
prostatic hyperplasia.The drugs are available in the hospital and also the sample drugs 
are used.The medical and surgical treatment on corresponding grades of Intravesical 
prostatic protrusion are compared after a period of three months for the efficacy as 
assessed by International prostatic  symptoms score,successful voiding in those 
presented with retention, uroflowmetry and Quality of life index.The pts who failed 
medical treatment are planned to undergo surgery after a period of 2 weeks and are 
observed whether they succeed in voiding or not.This is a non randomized prospective 
cohort study compared on the respective grades and the treatment is said to be effective 
and complete when uroflowmetry Peak flow > 15 ml/sec, IPSS mild or no symptoms, 
QOL improvement by >- 2 grades and IVPP absent or grade I.This comparison comes 
under Grade B Recommendation of evidence, as this is level II evidence. Statistical and 
graphical analysis was performed using computer software packages SPSS (Statistical 
Package for Social Sciences) 12.0 for Windows and Microsoft Excel 1997-2003. Those 
who fails medical treatment are planned to undergo Transurethral resection.Post 
surgically patients are not undertaken for Urodynamic evaluation as a measure to reduce 
the invasiveness and also not to interfere with the raw surface of the post resected 
prostatic bed.The patients presented with Acute urinary retention due to BPH with IVPP 
are categorized into respective grades and put into medical or surgical treatment based 
on the above protocol and analysed for the successful trial voiding.(Ref.Biblio.16). 
                                                                                                  
                              
                                             
                                             RESULTS
1.The Incidence of Intravesical prostatic protrusion presented to our department in those 
who presented with Lower urinary tract symptoms due to Benign prostatic hyperplasia is 
around 1 : 5.(100:516)
2.Mean Age-64 (100 men)

















































5.IVPP and Correlation(all 100 patients)
6. AUR and IVPP: 34 patients had acute urinary retention with Intravesical prostatic 
protrusion due to Benign prostatic hypertrophy.(34%).85% of AUR pts had IVPP >5 
mm.






























IVPP Medical Rx TURP
Grade I 12 16
Grade II 11 32
Grade III 5 24
11.Comparing the medical and surgical treatment(12 cases of grade I put under medical 
Rx compared with 12 cases of grade I underwent TURP.Similarly 11 cases of grade II 
and 5 cases of grade III are compared)
Grade I:                
Parameters Medical Rx TURP
IPSS Mean decrease by 2 5
PF Mean increase 1 3
IVPP Mean decrease 0 --
QOL Mean decrease 0 0
Coefficient _0.121 0.351
P value <0.231 <0.034
Grade II:                
Parameters Medical Rx TURP
IPSS Mean decrease by 2 7
PF Mean increase 1 4
IVPP Mean decrease 0 --
QOL Mean decrease 0 1
Coefficient _0.211 0.381
P value <0.311 <0.022
Grade III:                
Parameters Medical Rx TURP
IPSS Mean decrease by 2 9
PF Mean increase 1 5
IVPP Mean decrease 0 --
QOL Mean decrease 0 1
Coefficient _0.241 0.421
P value <0.351 <0.014
12.AUR and IVPP
IVPP AUR Pts No Medical 
Rx
TURP
Grade I 5 2 3
Grade II 11 1 10
Grade III 18 1 17
One pt of Grade I IVPP voided well with medical treatment with follow up period of  9 
months. Other patients of AUR (of all grades IVPP) put under medical treatment failed 
trial voiding and later proceeded with TURP and succeded trial voiding. All these 
patients had PFS and detrussor instability is ruled out in all cases. 
 
                                             DISCUSSION
Totally around 516 patients presented with Lower urinary tract symptoms due to 
clinically diagnosed Benign prostatic hypertrophy are screened with Transabdominal 
ultrasound to pick up 100 cases of Intravesical postatic protrusion. Thus the Incidence of 
Intravesical prostatic protrusion presented to our department in those who presented 
with Lower urinary tract symptoms due to Benign prostatic hyperplasia is around 1 : 5.
(100:516).The mean age is 64(100 men).Majority of the patients are in the age group 
between 55 and 70 years.52% of the patients presented with both obstructive and storage 
symptoms and the percentage of patients who presented only with obstructive symptoms 
is 32%
Majority of the patients are in Grade II IVPP (43%) whereas the incidence of Grade I 
and Grade II patients is almost the same. Moreover the values of all parameters in each 
grade are more or less similar accepting the reasonability for taking 5 mm criteria for the 
grade classification as shown in various literature. All the Grades of IVPP are correlated 
with IPPS score,QOL index,Q max,PVR and Prostatic volume and the significance is 
calculated using linear regression analysis and Pearson correlation coefficient.The 
increasing grades of IVPP are significantly directly correlated with IPSS score(r 0.163, p 
<0.037),Q max (r 0.231 p<0.027) and Postvoid residual (r 0.331 p<0.031).Among the 
three Qmax is the best correlated one.The Prostatic volume (p<0.131) and QOL 
index(p<0.053) do not correlate well with IVPP.
The percentage of the patients who presented with acute urinary retention is 34%. Only 
15% of the grade I IVPP patients presented with AUR and rest of the others (85%) had 
grade II & III IVPP. Eventhough many patients had postvoid residual more than 150 ml 
only those accepted for catheterisation and had partial distension even after voiding are 
catheterized. Cystoscopy is done in all patients and majority of them had enlargement of 
both lateral and median lobes (57%).Median lobe alone is presented as IVPP in 31% and 
lateral lobe alone is in 12%.Majority of the grade II & III IVPP in TAUS showed 
trilobar prostatic enlargement in cystoscopy.   
Urodynamics are done according to the "good urodynamic practices” recommended by 
the International Continence Society. Bladder outlet obstruction index (BOOI), defined 
as the detrusor's pressure at the maximum urinary flow (pdet_qmax) minus two times 
the maximum flow (qmax): BOOI = pdet_qmax - 2 x qmax. Values below 20 were 
considered non-obstructed, between 20 and 40 inconclusive and higher than 40, 
obstructed.But we have classified the values into two in this study whether obstructed or 
not obstructed ie above 40 is obstructed and below 40 is not obstructed. Pressure flow 
study is done only in 61 patients(out of 100) as the Urodynamic machine (Delphis TM 
Laborie) is available only from mid 2007 in our department. 71% of grade I, 78% of 
grade II and 88% of grade III IVPP had significant obstruction (BOOI >40) 
demonstrated with pressure flow study(p<0.011).The equivocal criteria in PF 
study(BOOI 20-40) is not considered in this study and BOOI >40 are considered as 
obstructed whereas BOOI <40 are considered as non obstructed. IPPS score(with the 
criteria >21 as significant),Qmax(with the criteria >10ml/sec as significant) and 
PVR(with the criteria >50ml as significant) are significantly and directly correlated with 
the obstruction as demonstrated by the Pressure flow study.(p<0.041,p<0.031 and 
p<0.041respectively) whereas the Prostatic volume and QOL index comparatively have 
lesser significance in assessing the obstruction.(p<0.142 and p<0.167 respectively). 
Those patients presented with AUR after the period of mid 2007, made their catheter 
removed and proceeded with pressure flow study.With the  urodynamic catheter in situ 
they are proceeded with voiding study and they voided  minimally eventhough they 
didn’t void in the previously conducted uroflowmetry machine.
Based on their significant criteria for obstruction as mentioned above and 2*2 table 
mode statistical analysis, Qmax,PVR and IPSS have good positive predictive 
values(PPV 72,68 and 58 respectively) for assessing the severity of obstruction as 
confirmed by Pressure flow study. Among the three Qmax alone have a good negative 
predictive value(NPV 69) whereas others have similar NPV(around 44).IVPP along with 
Qmax and PVR is correlated for obstruction as demonstrated by PFS and analysed 
statistically using computer software packages SPSS (Statistical Package for Social 
Sciences) and Positive predictive value calculator 9.0.IVPP have a very good positive 
and negative predictive value(78,73) and also a good accuracy rate(78) in comparison 
with all other parameters in predicting the BOO.This is especially very significant in 
increasing grades of protrusion. In conclusion, from this prospective analysis, the IVPP 
correlates significantly with BOO; it should be used as one of the variables initially 
assessed in men with LUTS, being a less invasive (than pressure-flow studies in every 
patient) and a more cost-effective way to stratify patients with LUTS for further 
management.
 On the treatment aspect,those patients who are fit and willing for surgery and those 
patients indicated for surgery are proceeded with conventional TURP.others are put 
under medical treatment.This comparison comes under Grade B Recommendation of 
evidence,as this is level II evidence. Statistical and graphical analysis was performed 
using computer software packages SPSS (Statistical Package for Social Sciences) 12.0 
for Windows and Microsoft Excel 1997-2003.No patients underwent open 
prostatectomy as no one had prostatic volume greater than 75 cc.
Comparing the medical and surgical treatment(12 cases of grade I put under medical Rx 
compared with 12 cases of grade I underwent TURP.Similarly 11 cases of grade II and 5 
cases of grade III are compared) TURP showed a very good and significant mean 
decrease of IPSS and Qmax(p<0.014 to 0.034;r 0.351 to 0.421) whereas those had 
medical treatment showed only a mean decrease of 2 in IPSS score and 1 in Qmax 
(p<0.231 to 0.351;r _0.241 to _0.121) in all grades irrespectively. The patients who 
showed improvement in IPSS score with medical treatment had storage symptoms 
especially before the treatment.There is no decrease in the measurement of IVPP in 
those patients with medical treatment whereas TURP patients showed no demonstrable 
protrusion.The QOL index decreased by mean 1 in those underwent TURP whereas the 
mean decrease is zero in those who had medical treatment.One pt of Grade I IVPP 
voided well with medical treatment with follow up period of  9 months. Other patients of 
AUR (of all grades IVPP) put under medical treatment failed trial voiding and later 
proceeded with TURP and succeded trial voiding. All these patients had PFS and 
detrussor instability is ruled out in all cases. So surgical intervention statistically proved 
to be superior to medical treatment in IVPP patients, especially most significant in 
Grade II & III IVPP patients.
                    
                                      
 
                                        CONCLUSION                           
1. The increasing grades of IVPP are significantly directly correlated with IPSS score,Q 
max and Postvoid residual. Among the three Qmax is the best correlated one.The 
Prostatic volume and QOL index do not correlate well with IVPP.
2. IVPP have a very good positive and negative predictive value and also a good 
accuracy rate in comparison with all other parameters in predicting the BOO.This is 
especially very significant in increasing grades of protrusion.Thus  the IVPP 
correlates significantly with BOO; it should be used as one of the variables initially 
assessed in men with LUTS, being a less invasive (than pressure-flow studies in 
every patient) and a more cost-effective way to stratify patients with LUTS for 
further management.
3. The surgical intervention statistically proved to be superior to medical treatment in 
IVPP patients, especially most significant in Grade II & III IVPP patients.
4. In patients presented with AUR along with IVPP surgery proved the efficacy for 
succeful trial voiding.The patients failed medical treatment voided succefully after 
TURP.
                                            Case Proforma                              
       Intravesical Prostatic Protrusion(IVPP) 
Sl.No
Name                                                                           Age
Address                                                                       Ph.no
Presenting complaints    




IPSS Score   ___   
Mild      (0-7)
Modrate(8-18)
Severe (19-35) 
QOL Index  ___
Urine Routine
Urine C&S
Blood   Urea
             Creatinine
             Sugar        
Xray KUB
Uroflowmetry:                      






                 Kidneys
                 Ureters
                 Bladder
                 Prostatic volume
                 PVR
                 IVPP_____
                                         
Grade(mm)
I   (1-5)
II (6-10) 
III(11-15) 




                                                BOOI:
MEDICAL TREATMENT
                                               Drugs
                                               Dosage
                                               Duration  
SURGERY        
               
                    Tissue resected
POSTOP/ AFTER MEDICAL Rx:
         IPSS
         QOL Index
         UROFLOWMETRY                                                                    Graph:
                   
Follow up PF MF VT VV
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